Trial Profile
A study to evaluate the effect of repeat oral doses of lamotrigine on cardiac conduction as assessed by 12-lead ECG [electrocardiogram] as compared to placebo and single oral doses of moxifloxacin
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 23 Aug 2023
Price :
$35
*
At a glance
- Drugs Lamotrigine (Primary) ; Moxifloxacin
- Indications Bipolar disorders; Epilepsy
- Focus Adverse reactions
- Sponsors GlaxoSmithKline
- 19 Mar 2007 New trial record.